Clinical trials
Recruiting Phase 2 trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
2,285 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 4 |
| 2018 | 4 |
| 2019 | 15 |
| 2020 | 32 |
| 2021 | 62 |
| 2022 | 123 |
| 2023 | 258 |
| 2024 | 552 |
| 2025 | 732 |
| 2026 | 499 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 2,285 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fudan University | 137 |
| Sun Yat-sen University | 118 |
| Institute of Hematology & Blood Diseases Hospital, China | 74 |
| Tianjin Medical University Cancer Institute and Hospital | 65 |
| Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 61 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 56 |
| The First Affiliated Hospital with Nanjing Medical University | 51 |
| Ruijin Hospital | 42 |
| Peking Union Medical College Hospital | 40 |
| Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 31 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 153 |
| Breast Neoplasms | 106 |
| Carcinoma, Hepatocellular | 77 |
| Colorectal Neoplasms | 70 |
| Stomach Neoplasms | 60 |
| Esophageal Squamous Cell Carcinoma | 53 |
| Esophageal Neoplasms | 47 |
| Recurrence | 47 |
| Lung Neoplasms | 43 |
| Pancreatic Neoplasms | 42 |
Trials
Showing 1 to 25 of 2,285. Each trial links to its page on Pharma Observatory.
2,185 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.